Dianthus Therapeutics, Inc. /DE/ (DNTH)
Latest DNTH Insider Trades
About Dianthus Therapeutics, Inc. /DE/ (DNTH)
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
- NEW YORK, NY
- 92
- 2023
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 30 | 287,084 | $29.62M |
| Option exercise | 30 | 604,168 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
DNTH Insider Transactions (Form 4)
12737 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Simon Read - Director | Option exercise | Common Stock | 2,778 |
Recent DNTH Form 8-K Filings
5Recent DNTH Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ANNE M MCGEORGE | Director | 7,750 | $844K | View on EDGAR | |
| ADAM VENESS | Officer |
DNTH Insider Trading - FAQ
What is the latest insider trade for DNTH?
Dianthus Therapeutics, Inc. /DE/ (DNTH) had 9 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for DNTH runs to 37 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying DNTH stock?
No insider purchases of DNTH were filed in the last 90 days.
How many insiders are selling DNTH stock?
30 insider sales of DNTH were filed in the last 90 days, totaling $29.62M.
Where can I see DNTH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks DNTH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow DNTH insider buys?
Create a free InsiderAlpha account and press Watch on this page to add DNTH to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Simon Read view on EDGAR
- - Adam M. Veness view on EDGAR
- - Anne McGeorge view on EDGAR
- - Simon Read view on EDGAR
- - Adam M. Veness view on EDGAR
- - Marino Garcia view on EDGAR
- - Ryan Savitz view on EDGAR
- - Adam M. Veness view on EDGAR
- - Simrat Randhawa view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where DNTH's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track DNTH insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
